Mobilization of peripheral stem cells for transplantation.
Nemunaitis
J
J
Baylor Medical Center/Sammons Cancer Center, Texas Oncology, Dallas 75204.
Rosenfeld
C
C
D000970:Antineoplastic Agents / Q000009:adverse effects; D001773:Blood Cells; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003114:Colony-Forming Units Assay; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006085:Graft Survival; D006410:Hematopoiesis / Q000187:drug effects*; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007937:Leukapheresis; D009369:Neoplasms / Q000628:therapy; D010198:Pancytopenia / Q000139:chemically induced / Q000628:therapy
D000970:Antineoplastic Agents; D016298:Hematopoietic Cell Growth Factors; D003520:Cyclophosphamide